A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis

PHASE3CompletedINTERVENTIONAL
Enrollment

441

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

January 31, 2013

Study Completion Date

February 28, 2013

Conditions
HyperphosphatemiaKidney Failure
Interventions
DRUG

ferric citrate, ca acetate, sevelamer carbonate, placebo

All intervention doses will be based on serum phosphorus levels and/or drug label requirements

Trial Locations (56)

11212

Brookdale Physician's Dialysis Associates, Brooklyn

19104

University of Pennsylvania Health System, Philadelphia

20850

Rockville Dialysis Center, Rockville

22030

Clinical Research & Consulting Center, LLC, Fairfax

22033

Nephrology Associates of Northern Virginia, Inc., Fairfax

22908

Nephrology Clinical Research Center, Charlottesville

23249

McGuire VA Medical Center, Richmond

23666

Peninsula Kidney Associates, Hampton

27157

Wake Forest University School of Medicine, Winston-Salem

27705

Duke University Medical Center Division of Nephrology, Durham

28207

Metrolina Nephrology Associates, PA, Charlotte

28401

Trial Management Associates, Wilmington

28801

Mountain Kidney and Hypertension Associates, PA, Asheville

30030

Atlanta Nephrology Referral Center, Decatur

30901

Kidney Care Associates, LLC, Augusta

32216

Mayo Clinic, Jacksonville

33028

Pines Clinical Research, Inc., Pembroke Pines

33458

ASA Clinical Research, LLC, Jupiter

33511

PAB Clinical Research, Brandon

34471

Ocala Kidney Group, Ocala

37205

Nephrology Associates, PC, Nashville

37404

Southeast Renal Research Institute Nephrology Associates, Chattanooga

43210

The Ohio State University Division of Nephrology, Columbus

44195

Cleveland Clinic Foundation Q7-150 Nephrology, Cleveland

44718

Clinical Research Limited, Canton

45267

Division of Nephrology and Hypertension Department of Internal Medicine University of Cincinnati College of Medicine, Cincinnati

46360

Nephrology Specialists, PC, Michigan City

48195

Nephrology Hypertension Clinic, Southgate

48202

Henry Ford Hospital, Detroit

48341

Michigan Kidney Consultants, PC, Pontiac

53226

Medical College of Wisconsin Froedert Memorial Lutheran Hospital Division of Nephrology, Milwaukee

60607

Circle Medical Management, Chicago

64128

Kansas City VA Medical Center, Kansas City

70112

LSU Health Sciences Center Section of Nephrology and Hypertension Department of Internal Medicine, New Orleans

73116

DaVita, Oklahoma City

75390

UT Southwestern Medical Center at Dallas, Dallas

77030

Kidney Associates, Houston

Nephrology, PA, Houston

77384

Kidney Specialists of North Houston, PLLC, The Woodlands

80031

Western Nephrology, Westminster

80045

University of Colorado Denver, Aurora

84132

University of Utah Health Sciences Center, Salt Lake City

85284

Southwest Clinical Research Institute, LLC, Tempe

90048

Tower Nephrology Medical Group, Los Angeles

90073

Veterans Administration Greater Los Angeles Healthcare System, West Los Angeles, Los Angeles

90603

American Institute of Research, Whittier

92505

Apex Research of Riverside, Riverside

02111

Tufts Medical Center, Boston

01040

Pioneer Valley Nephrology, Holyoke

01107

Western New England Renal & Transplant Associates, Springfield

37232-1371

Vanderbilt University Medical Center Clinical Trials Center, Nashville

05401

University of Vermont/ Fletcher Allen Health Care; Renal Services, Burlington

Unknown

Department of Nephrology and Hypertension Brazilai Medical Center, Ashkelon

Tel Aviv Sourasky Medical Center Nephrology Department, Tel Aviv

00936-5067

RCMI-Clinical Research Center Medical Sciences Campus University of Puerto Rico, Rio Piedras

00976

Puerto Rico Renal Health & Research Center, Inc/ Atlantic Healthcare Group, Inc, Trujillo Alto

Sponsors
All Listed Sponsors
lead

Keryx Biopharmaceuticals

INDUSTRY